Rapid Therapeutic Announces Its Plans to Utilize Its Proprietary Technology to Address Broad Applications for Delivery of Medications via the Pulmonary System to Focus on Addressable Markets of Over $7 Billion

Stock Information for Rapid Therapeutic Science Laboratories Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.